PATENT CLAIM ANALYSIS

Application Number: 16138698
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-08
Patent Classification: ["514", "051000"]

Abstract:
Cytidine nucleoside analogues of Formula I, wherein the variables are as described herein, in combination with uridine nucleoside analogues of Formula II, wherein the variables are as described herein, produce a synergistic effect on the inhibition of HCV polymerase.

Claim (Index 32):
The method of  claim 31  wherein each R 3  is independently H, lower alkyl, lower haloalkyl, phenyl or phenyl lower alkyl.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 97.0
- Lexical Diversity: 1.57143
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15581834', '12402601', '10940615', '10131938', '13988354']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7905610017271049
- 35 USC 102 Novelty (BERT): 0.5493809384993487
- Combined Prediction Score: 0.7664429954043293
- Mean Citation Score: 388.826792
- Max Citation Score: 437.45496
- Similarity Product: 255.7161582426596

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test